UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Depressive illness in Parkinson's disease - indication of a more advanced and widespread neurodegenerative process?

Acta neurologica Scandinavica, 2008-05, Vol.117 (5), p.295-304

2008

Volltextzugriff (PDF)

Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients

Acta psychiatrica Scandinavica, 2000-05, Vol.101 (5), p.354-359

2000

Volltextzugriff (PDF)

Long-term effects of an educational program for general practitioners given by the Swedish Committee for the Prevention and Treatment of Depression

Acta psychiatrica Scandinavica, 1992-01, Vol.85 (1), p.83-88

1992

Volltextzugriff (PDF)

Prevalence, incidence and sex ratio of transsexualism

Acta psychiatrica Scandinavica, 1996-04, Vol.93 (4), p.221-223

1996

Volltextzugriff (PDF)

Factors predictive of regret in sex reassignment

Acta psychiatrica Scandinavica, 1998-04, Vol.97 (4), p.284-289

1998

Volltextzugriff (PDF)

Frequency of suicide on Gotland after systematic postgraduate education of general practitioners

Acta psychiatrica Scandinavica, 1989-08, Vol.80 (2), p.151-154

1989

Volltextzugriff (PDF)

Prevention of male suicides: lessons from Gotland study

The Lancet (British edition), 1995-02, Vol.345 (8948), p.524-524

1995

Volltextzugriff (PDF)

Male depression and suicide

International clinical psychopharmacology, 2001-03, Vol.16 Suppl 2 (Supplement 2), p.S21-S24

2001

Volltextzugriff (PDF)

Cost-effectiveness of clozapine treatment in therapy-refractory schizophrenia

Acta psychiatrica Scandinavica, 1995-09, Vol.92 (3), p.199-201

1995

Volltextzugriff (PDF)

Light treatment of seasonal affective disorder in combination with citalopram or placebo with 1-year follow-up

International clinical psychopharmacology, 1999, Vol.14, p.S7-S11

1999

Volltextzugriff (PDF)

Enantioselective analysis of citalopram and metabolites in adolescents

Therapeutic drug monitoring, 2001-12, Vol.23 (6), p.658-664

2001

Volltextzugriff (PDF)

Effect of an educational program for general practitioners on Gotland on the pattern of prescription of psychotropic drugs

Acta psychiatrica Scandinavica, 1990-12, Vol.82 (6), p.399-403

1990

Volltextzugriff (PDF)

Depression treatment--then, now and in the future

Läkartidningen, 2013, Vol.110 (9-10), p.493

2013

Volltextzugriff (PDF)

Cost-benefit analysis of an educational program for general practitioners by the Swedish Committee for the Prevention and Treatment of Depression

Acta psychiatrica Scandinavica, 1992-06, Vol.85 (6), p.457-464

1992

Volltextzugriff (PDF)

Clinical characteristics of a total cohort of female and male applicants for sex reassignment: a descriptive study

Acta psychiatrica Scandinavica, 1998-03, Vol.97 (3), p.189-194

1998

Volltextzugriff (PDF)

An educational program on depressive disorders for general practitioners on Gotland: background and evaluation

Acta psychiatrica Scandinavica, 1989-01, Vol.79 (1), p.19-26

1989

Volltextzugriff (PDF)

The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients

European neuropsychopharmacology, 1994-03, Vol.4 (1), p.1-6

1994

Volltextzugriff (PDF)

Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting

Journal of clinical psychopharmacology, 2002-08, Vol.22 (4), p.406-413

2002

Volltextzugriff (PDF)

Dexamethasone Suppression Test and Serum Prolactin in Dementia Disorders

British journal of psychiatry, 1983-09, Vol.143 (3), p.277-281

1983

Volltextzugriff (PDF)

Affective disorders. Diagnostics, epidemiology and neurobiology--three fields which played an important role for the development of effective therapeutic strategies

Läkartidningen, 2004-01, Vol.101 (1-2), p.103-108

Wålinder, Jan

2004

Volltextzugriff (PDF)

Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson’s disease and major depression

Journal of neurology, 2010-04, Vol.257 (4), p.524-532

2010

Volltextzugriff (PDF)

Suicide and antidepressive agents: Launch a modern psychiatric seafarer!

Läkartidningen, 2003-06, Vol.100 (26-27), p.2314

Wålinder, Jan

2003

Volltextzugriff (PDF)

We need a new psychiatry without involvement of incompetent persons

Läkartidningen, 2008-02, Vol.105 (7), p.421-422

2008

Volltextzugriff (PDF)

Mirtazapine naturalistic depression study (in Sweden)-MINDS(S): clinical efficacy and safety

Human psychopharmacology, 2006-04, Vol.21 (3), p.151-158

2006

Volltextzugriff (PDF)

ECT in Parkinson's disease. Changes in motor symptoms, monoamine metabolites and neuropeptides

Journal of Neural Transmission - Parkinson's Disease and Dementia Section, 1995-06, Vol.10 (2-3), p.129-140

1995

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(123)

Publikationsform

Artikel
(197)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(118)
Science & Technology
(103)
Life Sciences & Biomedicine
(93)
Female
(72)
Male
(72)
Psychiatry
(60)
Adult
(46)
Middle Aged
(42)
Biological And Medical Sciences
(40)
Medical Sciences
(37)
Aged
(31)
Sweden
(28)
Psychology. Psychoanalysis. Psychiatry
(23)
Medicin Och Hälsovetenskap
(22)
Adolescent
(19)
Neurosciences & Neurology
(17)
Clinical Neurology
(14)
Psychopathology. Psychiatry
(14)
Sweden - Epidemiology
(14)
Depressive Disorder - Drug Therapy
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Depressive illness in Parkinson's disease - indication of a more advanced and widespread neurodegenerative process?

Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients

Long-term effects of an educational program for general practitioners given by the Swedish Committee for the Prevention and Treatment of Depression

Prevalence, incidence and sex ratio of transsexualism

Factors predictive of regret in sex reassignment

Frequency of suicide on Gotland after systematic postgraduate education of general practitioners

Prevention of male suicides: lessons from Gotland study

Male depression and suicide

Cost-effectiveness of clozapine treatment in therapy-refractory schizophrenia

Light treatment of seasonal affective disorder in combination with citalopram or placebo with 1-year follow-up

Enantioselective analysis of citalopram and metabolites in adolescents

Effect of an educational program for general practitioners on Gotland on the pattern of prescription of psychotropic drugs

Depression treatment--then, now and in the future

Cost-benefit analysis of an educational program for general practitioners by the Swedish Committee for the Prevention and Treatment of Depression

Clinical characteristics of a total cohort of female and male applicants for sex reassignment: a descriptive study

An educational program on depressive disorders for general practitioners on Gotland: background and evaluation

The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients

Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting

Dexamethasone Suppression Test and Serum Prolactin in Dementia Disorders

Affective disorders. Diagnostics, epidemiology and neurobiology--three fields which played an important role for the development of effective therapeutic strategies

Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson’s disease and major depression

Suicide and antidepressive agents: Launch a modern psychiatric seafarer!

We need a new psychiatry without involvement of incompetent persons

Mirtazapine naturalistic depression study (in Sweden)-MINDS(S): clinical efficacy and safety

ECT in Parkinson's disease. Changes in motor symptoms, monoamine metabolites and neuropeptides

Suchergebnisse filtern